Velneperit
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
Shionogi · Phase 2 · Completed · Enrollment 842
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | Obesity or overweight | n/r | 54 | n/r | n/r |
| S-2367 1600 mg q.d. 54 weeks | Obesity or overweight | 1600 mg | 54 | n/r | n/r |
| S-2367 1600 mg q.d. 60 weeks | Obesity or overweight | 1600 mg | 54 | n/r | n/r |